Preventing coronary events by optimal control of blood pressure and lipids in patients with the metabolic syndrome.
Explore this paper's citation graph
Summary
Many CHD events in patients with MetS may be preventable by nominal or optimal control of lipids and/or blood pressure.
- Type
- article
- Published
- 2003-06-15
- Cited by
- 154
- References
- 8
- OpenAlex
- https://openalex.org/W2044428655
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:25012500
Keywords
Medicine, Blood pressure, Cholesterol, Framingham Heart Study, Internal medicine
References
- Clinical significance of cardiovascular dysmetabolic syndrome
- Cardiovascular morbidity and mortality associated with the metabolic syndrome.
- Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease.
- Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey.
- Weight-modification trials in older adults: what should the outcome measure be?
- Prediction of coronary heart disease using risk factor categories.
- Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B.
- The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure.
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
Cited by
- Assessment of cardiovascular risk and choice of antihypertensive therapy
- A randomized, double‐blind clinical trial to evaluate the efficacy and safety of a fixed‐dose combination of amlodipine/rosuvastatin in patients with dyslipidemia and hypertension
- Management of the metabolic syndrome.
- Prevalence of metabolic syndrome in a large health check-up population in Taiwan.
- Arterial hypertension - prevalence of risk factors and morbide associations that increase cardiovascular risk.
- Difficulties in achieving arterial hypertension control.
- Is a new waist circumference and BMI needed for African Americans for the diagnosis of metabolic syndrome
- Étude de l'implication des cellules musculaires lisses vasculaires dans la distensibilité et le phénotype thrombotique dans des modèles murins
- Guías de práctica clínica sobre diabetes, prediabetes y enfermedades cardiovasculares
- Hypertension, hypercoagulability and the metabolic syndrome: A cluster of risk factors for cardiovascular disease
- Gender‐specific aspects of treatment of cardiovascular risk factors in primary and secondary prevention
- Changes in arterial stiffness and other cardiovascular risk variables following specific exercise programmes
- Discovering the Full Spectrum of Cardiovascular Disease: Minority Health Summit 2003: Report of the Outcomes Writing Group
- [Guidelines on diabetes, pre-diabetes, and cardiovascular diseases].
- Cholesterol metabolism and its implications for therapeutic interventions in patients with hypercholesterolaemia
- Cardiometabolic health of Chinese older adults with diabetes living in Beijing, China.
- Impact of dyslipidemia on cardiovascular risk stratification of hypertensive patients and association of lipid profile with other cardiovascular risk factors: results from the ICEBERG study
- Intensified screening and treatment of the metabolic syndrome for cardiovascular risk reduction.
- Postmenopozal hormon tedavisi kardiyovasküler hastalık riskini azaltıyor muş
- Blood Pressure and Cholesterol Control in Hypertensive Hypercholesterolemic Patients: NHANES 1988–2010
Related papers
- Thrombogenic Risk Factors for Cardiovascular Disease in Dialysis Patients
- Contribution of Vascular Risk Factors to Dementia and Dementia Risk Prediction Varies Across Mid-to Later-Life: The Framingham Heart Study (P1-1.Virtual)
- State of the art coronary heart disease risk estimations based on the Framingham heart study.
- Description of the Framingham Heart Study data for Genetic Analysis Workshop 13
- Methods to identify increased risk of coronary disease in the general population: conclusion is oversimplification.
- Serum Uric Acid and Cardiovascular Disease Risk
- The Framingham Study: The Epidemiology of Atherosclerotic Disease
- Research on the statistical analysis methods of heart disease: taking the Framingham Heart Study as an example